Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

CYLD inhibits Neoplasm Invasiveness. 5 / 5

| 5

➶

reach

"These findings suggest that CYLD inhibits NPC development and provides strong evidence supporting a role for CYLD inhibiting fibroblast and endothelial stromal cell infiltration into NPC via suppressing the NF-kB pathway."

32708712

➶

reach

"SPATA2 and CYLD inhibit T cell infiltration into colorectal cancer via regulation of IFN-γ/STAT1 axis."

36531014

➶

reach

"Additionally, CYLD was able to inhibit fibroblast and endothelial stromal cell infiltration into the NPC tumor microenvironment."

32708712

➶

reach

"CYLD Suppresses Fibroblast and Endothelial Cell Infiltration in NPC TME."

32708712

➶

reach

"Single Cell Analysis Shows CYLD Suppresses Specific Stromal Cell Infiltration in the TME."

32708712

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...

Other Services

This Service

This Project

IndraLab

Statements

CYLD inhibits Neoplasm Invasiveness. 5 / 5

Our Sources:

Databases

Reading